欧洲各地的处方变化:对处方实践和教育需求的洞察
Mariëlle G Hartjes1,2,3, Milan C Richir1,2,4, Michiel A van Agtmael1,2
1Amsterdam UMC, location Vrije Universiteit Amsterdam, Department of Internal Medicine, unit Pharmacotherapy, Amsterdam, The Netherlands.
British journal of clinical pharmacology
|December 8, 2025
概括
欧洲的处方医生主要认为是务实上下文或指导方针导向的. 目前的教育涵盖了这些个人资料,但不足以代表经验驱动和以脆弱性为中心的方法,这些方法应该被整合起来,以改善处方实践.
科学领域:
- 医学教育 医学教育
- 药理学 药理学是指药理学的学科.
- 医疗保健专业培训 医疗保健专业培训
背景情况:
- 处方药物是复杂的,受到各种因素的影响.
- 有四种处方者概况:实用-上下文,指南导向,经验驱动和以脆弱性为重点.
- 这些个人资料在欧洲处方医生中的流行程度以及它们在教育中的整合仍然不清楚.
研究的目的:
- 评估欧洲处方者与四个不同的个人资料的识别.
- 评估这些资料在临床药理学和治疗学 (CPT) 教育中的覆盖范围.
- 为改善处方教育和实践提供信息.
主要方法:
- 一项横截面调查分发给欧洲各地的医生,医生助理,高级护士从业人员和处方药师.
- 参与者将他们的身份与四个处方者个人资料排名.
- 他们还表示认可这些档案在同事和他们的覆盖在CPT教育.
主要成果:
- 来自23个欧洲国家的170名处方医生参与了.
- 大多数被认为是务实上下文 (36.5%) 或以指导方针为导向 (42.9%).
- 经验驱动的 (11.2%) 和关注脆弱性的 (9.4%) 个人资料是不太常见的自我认同. 在CPT教育中涵盖了实用上下文和指导方针导向的处方,而以脆弱性为重点的处方代表性较差.
结论:
- 专业背景,临床环境和经验显著影响欧洲的处方方法.
- 目前的CPT课程与实用上下文和指导方针导向的个人资料的普遍性保持一致.
- 虽然在实践中观察到基于经验和以脆弱性为重点的个人资料,但需要在教育策略中更加强调,以加强处方实践.
相关概念视频
01:24Dosage Regimen: Individualization
154
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
154
01:02Prescription, Nonprescription and Orphan Drugs
1.1K
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.1K
01:28Dosage Regimens: Designs and Approaches
242
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
242
01:15Drug Dosing: Geriatric Patients
212
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
212
01:27Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
135
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
135
01:22Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
167
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
167